Cell Painting: a decade of discovery and innovation in cellular imaging
- PMID: 39639168
- PMCID: PMC11810604
- DOI: 10.1038/s41592-024-02528-8
Cell Painting: a decade of discovery and innovation in cellular imaging
Erratum in
-
Author Correction: Cell Painting: a decade of discovery and innovation in cellular imaging.Nat Methods. 2025 Feb;22(2):447. doi: 10.1038/s41592-024-02578-y. Nat Methods. 2025. PMID: 39668211 Free PMC article. No abstract available.
Abstract
Modern quantitative image analysis techniques have enabled high-throughput, high-content imaging experiments. Image-based profiling leverages the rich information in images to identify similarities or differences among biological samples, rather than measuring a few features, as in high-content screening. Here, we review a decade of advancements and applications of Cell Painting, a microscopy-based cell-labeling assay aiming to capture a cell's state, introduced in 2013 to optimize and standardize image-based profiling. Cell Painting's ability to capture cellular responses to various perturbations has expanded owing to improvements in the protocol, adaptations for different perturbations, and enhanced methodologies for feature extraction, quality control, and batch-effect correction. Cell Painting is a versatile tool that has been used in various applications, alone or with other -omics data, to decipher the mechanism of action of a compound, its toxicity profile, and other biological effects. Future advances will likely involve computational and experimental techniques, new publicly available datasets, and integration with other high-content data types.
© 2024. Springer Nature America, Inc.
Conflict of interest statement
Competing interests: S. Singh and A.E.C. serve as scientific advisors for companies that use image-based profiling and Cell Painting (A.E.C.: Recursion, SyzOnc, Quiver Bioscience; S. Singh: Waypoint Bio, Dewpoint Therapeutics, DeepCell) and receive honoraria for occasional talks at pharmaceutical and biotechnology companies. J.C.P. and O.S. declare ownership in Phenaros Pharmaceuticals. M.-A.T. and N.G. were formerly employed at AstraZeneca. M.-A.T. and N.G. are currently employed at Recursion Pharmaceuticals. The remaining authors declare no competing interests.
Figures




Similar articles
-
A Decade in a Systematic Review: The Evolution and Impact of Cell Painting.bioRxiv [Preprint]. 2024 May 7:2024.05.04.592531. doi: 10.1101/2024.05.04.592531. bioRxiv. 2024. PMID: 38766203 Free PMC article. Preprint.
-
A Decade in a Systematic Review: The Evolution and Impact of Cell Painting.ArXiv [Preprint]. 2024 May 4:arXiv:2405.02767v1. ArXiv. 2024. PMID: 38745696 Free PMC article. Preprint.
-
Phenotypic Profiling of Reference Chemicals across Biologically Diverse Cell Types Using the Cell Painting Assay.SLAS Discov. 2020 Aug;25(7):755-769. doi: 10.1177/2472555220928004. Epub 2020 Jun 17. SLAS Discov. 2020. PMID: 32546035 Free PMC article.
-
Phenotypic Image Analysis Software Tools for Exploring and Understanding Big Image Data from Cell-Based Assays.Cell Syst. 2018 Jun 27;6(6):636-653. doi: 10.1016/j.cels.2018.06.001. Cell Syst. 2018. PMID: 29953863 Review.
-
Optimizing the Cell Painting assay for image-based profiling.Nat Protoc. 2023 Jul;18(7):1981-2013. doi: 10.1038/s41596-023-00840-9. Epub 2023 Jun 21. Nat Protoc. 2023. PMID: 37344608 Free PMC article. Review.
Cited by
-
Prediction of Bioactive Metabolites from American Aconitum Using Network Integrating Cellular Morphological Profiling and Mass Spectrometry Data.J Nat Prod. 2025 Jul 25;88(7):1557-1567. doi: 10.1021/acs.jnatprod.4c01458. Epub 2025 Jul 11. J Nat Prod. 2025. PMID: 40645164 Free PMC article.
-
More than just life and death: advances in imaging and analysis for 3D-bioprinted tissues.Front Bioeng Biotechnol. 2025 Jun 11;13:1600077. doi: 10.3389/fbioe.2025.1600077. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40567257 Free PMC article.
-
Combining phenomics with transcriptomics reveals cell-type-specific morphological and molecular signatures of the 22q11.2 deletion.Nat Commun. 2025 Jul 9;16(1):6332. doi: 10.1038/s41467-025-61547-x. Nat Commun. 2025. PMID: 40634302 Free PMC article.
-
Digital Alchemy: The Rise of Machine and Deep Learning in Small-Molecule Drug Discovery.Int J Mol Sci. 2025 Jul 16;26(14):6807. doi: 10.3390/ijms26146807. Int J Mol Sci. 2025. PMID: 40725054 Free PMC article. Review.
-
Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes.bioRxiv [Preprint]. 2025 Jan 24:2025.01.22.634152. doi: 10.1101/2025.01.22.634152. bioRxiv. 2025. PMID: 39896617 Free PMC article. Preprint.
References
-
- Swinney DC & Anthony J How were new medicines discovered? Nature Reviews Drug Discovery 2011 10:7 10, 507–519 (2011). - PubMed
-
- Moffat JG, Vincent F, Lee JA, Eder J & Prunotto M Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nature Reviews Drug Discovery 2017 16:8 16, 531–543 (2017). - PubMed
-
- Perlman ZE et al. Multidimensional drug profiling by automated microscopy. Science (1979) 306, 1194–1198 (2004). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources